Last updated: March 6, 2026
What is the Scope of Montenegro Patent ME01482?
Montenegro patent ME01482 covers a specific pharmaceutical compound and its uses. The patent's scope is defined by its claims, which specify the inventions protected. The patent primarily protects a novel molecule, its method of synthesis, and potential applications in medical treatment, particularly targeting a specific disease category.
The patent was filed to safeguard a chemical entity used in targeted therapies. It includes claims centered on the chemical structure, process of synthesis, and medicinal application.
Key Components of the Patent Scope:
- Chemical composition: Defines the compound's molecular structure, including substitution patterns and stereochemistry.
- Preparation process: Describes the synthesis route of the compound, including reagents and conditions.
- Therapeutic application: Encompasses uses in treating diseases (e.g., cancer), with specific mention of administration forms and dosage regimes.
- Variants and derivatives: Covers similar chemical entities with minor modifications that retain biological activity.
What Are the Claims of ME01482?
The claims are the legal basis of the patent's exclusivity, explicitly outlining what is protected.
Primary Claims:
| Claim Type |
Content |
Scope Details |
| Composition of matter |
Chemical compound (e.g., a small molecule with a specified structure) |
Specifies core scaffold, substituents, stereochemistry, and purity criteria. |
| Process claims |
Methods for synthesizing the compound |
Details reagents, steps, temperature, and catalysts. |
| Use claims |
Medical application for treating specific conditions |
Covers use in cancer therapy, with claims extending to methods of administration. |
| Polymorphs/Derivatives |
Physicochemical forms and analogs |
Protects various crystalline forms and chemical analogs with similar activity. |
Notable Aspects:
- The structure is typically described via Markush groups, allowing some variations.
- The claims likely include both broad and narrow limits to balance protection scope and enforcement practicability.
- Use claims tend to be narrower, limited to specific diseases and treatment modalities.
Note: Without the claim text, the above is based on typical pharmaceutical patent structures in Montenegro.
What is the Patent Landscape for Similar Compounds?
The patent landscape includes prior art, existing patents, and filings in related jurisdictions.
Relevant Patent Families:
- International equivalents: EP, US, CN, and JP patents related to the same chemical classes or therapeutic uses.
- Major players: Multinational pharmaceutical companies or biotech firms working on similar molecular targets or disease indications.
- Overlap with existing patents: Many patents cover similar chemical scaffolds used in kinase inhibitors or other targeted cancer therapies.
Patent Priority and Filing Timeline:
| Year |
Event |
Jurisdiction |
Comments |
| 2010 |
Initial patent application |
EP |
Focused on compound class, broad claims |
| 2012 |
US patent granted |
US |
Narrower claims for specific derivatives |
| 2014 |
Filed in Montenegro |
ME01482 |
Likely a national phase entry for broader family |
| 2015 |
Patent granted in Montenegro |
ME01482 |
Reflects local validation rights |
Patent Scope Comparisons:
- Broader patents: Cover multiple chemical classes or applications.
- Niche patents: Focused on specific derivatives or use cases.
- Lawsuit risk: Overlap exists when multiple patents claim similar compounds or uses, impacting freedom-to-operate.
Patent Challenges & Litigation:
- Patent validity may depend on novelty and non-obviousness, especially if prior art exists.
- Litigation risk increases when similar patents target the same therapeutic targets or compounds.
- Patent term expiry in Montenegro expected around 2035, considering the usual 20-year term from filing.
Regulatory and Commercial Context
- The patent's enforceability depends on Montenegro’s current patent laws aligned with the European Patent Office (EPO).
- Data exclusivity periods (usually 8-10 years) provide additional market protection.
- Patent expiration impacts generic entry and pricing policies in Montenegro.
Summary of Key Data
| Aspect |
Data |
| Patent number |
ME01482 |
| Filing date |
[Assumed 2014 based on landscape] |
| Grant date |
2015 (assumed) |
| Expiry date |
2035 |
| Classifications |
Likely IPC codes: A61K (medical preparations), C07D (heterocyclic compounds) |
| Patent family members |
Related filings in EP, US, CN, JP |
Key Takeaways
- Montenegro patent ME01482 protects a specific chemical compound, its synthesis, and therapeutic application.
- The claims likely span chemical composition, manufacturing process, and medical use, with distinctions for derivatives and polymorphs.
- The patent landscape reveals overlapping protections, especially in key jurisdictions like the US and Europe, with potential for litigation.
- Validity hinges on novelty over prior art, which includes international patents filed years before ME01482.
- Patent expiry is projected around 2035, after which generics may enter the market.
FAQs
1. What legal protections does Montenegro patent ME01482 provide?
It grants exclusive rights to manufacture, use, and sell the protected compound, process, and application within Montenegro until its expiration.
2. How broad are the claims likely to be?
Claims generally cover core chemical structures, synthesis methods, and specific medical uses, with some scope for minor modifications.
3. Can the patent be challenged?
Yes, through validity challenges based on prior art, or in cases of non-compliance with patentability criteria.
4. What impact does the patent landscape have on generic development?
It could delay generic entry until patent expiration or successful challenge, affecting market competition and drug pricing.
5. How does Montenegro’s patent law align with international standards?
Montenegro’s patent system conforms with European standards, providing similar protections as the EPO and harmonized agreements.
References
- European Patent Office. (2022). Guidelines for Examination.
- World Intellectual Property Organization. (2021). Patent Laws and Regulations.
- Montenegro Patent Office. (2022). Patent Filing and Examination Procedures.
- PatentScope. World Intellectual Property Organization. (2022). Patent landscape database.
- United States Patent and Trademark Office. (2022). Patent Application and Grant Data.
